| Literature DB >> 25848751 |
Hiromichi Suzuki1, Kosuke Aoki1, Kenichi Chiba2, Yusuke Sato3, Yusuke Shiozawa3, Yuichi Shiraishi2, Teppei Shimamura4, Atsushi Niida2, Kazuya Motomura5, Fumiharu Ohka6, Takashi Yamamoto5, Kuniaki Tanahashi5, Melissa Ranjit5, Toshihiko Wakabayashi5, Tetsuichi Yoshizato3, Keisuke Kataoka3, Kenichi Yoshida3, Yasunobu Nagata3, Aiko Sato-Otsubo3, Hiroko Tanaka2, Masashi Sanada3, Yutaka Kondo7, Hideo Nakamura8, Masahiro Mizoguchi9, Tatsuya Abe10, Yoshihiro Muragaki11, Reiko Watanabe12, Ichiro Ito12, Satoru Miyano2, Atsushi Natsume5, Seishi Ogawa3.
Abstract
Grade II and III gliomas are generally slowly progressing brain cancers, many of which eventually transform into more aggressive tumors. Despite recent findings of frequent mutations in IDH1 and other genes, knowledge about their pathogenesis is still incomplete. Here, combining two large sets of high-throughput sequencing data, we delineate the entire picture of genetic alterations and affected pathways in these glioma types, with sensitive detection of driver genes. Grade II and III gliomas comprise three distinct subtypes characterized by discrete sets of mutations and distinct clinical behaviors. Mutations showed significant positive and negative correlations and a chronological hierarchy, as inferred from different allelic burdens among coexisting mutations, suggesting that there is functional interplay between the mutations that drive clonal selection. Extensive serial and multi-regional sampling analyses further supported this finding and also identified a high degree of temporal and spatial heterogeneity generated during tumor expansion and relapse, which is likely shaped by the complex but ordered processes of multiple clonal selection and evolutionary events.Entities:
Mesh:
Year: 2015 PMID: 25848751 DOI: 10.1038/ng.3273
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330